The Benefits of MicroCor in Ambulatory Decompensated Heart Failure (BMAD) Trial demonstrated the impact of utilizing ZOLL® Heart Failure Management System* (HFMS) for fluid management following an acute decompensation event.
Early Pulmonary Fluid Detection and Improved Outcomes
Pulmonary fluid can accumulate days before patients experience noticeable symptoms, and can be an early indicator of a heart failure decompensation event
How ZOLL HFMS Works
ZOLL HFMS is a non-invasive, patch-based device that uses novel radiofrequency technology for early detection of changes in pulmonary fluid levels, an increase in which is an early indicator of heart failure decompensation.
Radar waves can be used to measure interstitial edema, an early sign of heart failure
Changes in signal path delay and strength indicate changes in fluid Waves are highly modulated by tissue hydration, producing a very sensitive, robust measurement known as Thoracic Fluid Index (TFI)
ZOLL HFMS also records, stores, and transmits additional patient data that can be used to inform care plans, including heart rate, respiration rate, activity, posture, and heart rhythm (ECG).